ArticleNeuroimage. Reports2025
Relaxation-compensated chemical exchange saturation transfer MRI in the cervical spinal cord at 3T: An application in multiple sclerosis.
Article in Neuroimage. Reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system, characterized by demyelination. Exploring pathological changes in the spinal cord could improve our understanding of the mechanisms that cause neurological dysfunction and clinical symptoms; however, conventional MRI is not sensitive to molecular changes within the tissue. Chemical exchange saturation transfer (CEST) can probe tissue biochemistry with high resolution and sensitivity, without exogenous contrasts. However, CEST measurements in vivo are contaminated by concurrent effects including semi-solid magnetization transfer (MT), direct water saturation, and T1-relaxation, which can be altered in MS and need to be removed to accurately quantify changes. Fifty-three people with relapsing-remitting MS (pwRRMS) and 45 healthy controls (HCs) were imaged at 3 T to quantify amide and nuclear Overhauser enhancement (NOE) CEST effects in the cervical spinal cord. Using Lorentzian fitting, confounding effects were removed, and the apparent exchange-dependent relaxation (AREX) contrast was calculated. Uncorrected and corrected AREX amide and NOE contrasts were compared across groups and tissue types. In pwRRMS, AREX NOE was significantly different in lesions compared to normal-appearing white matter. Greater heterogeneity in both CEST contrasts was observed in pwRRMS compared to the HCs. In a sub-analysis of pwRRMS separated by neurological disability, AREX amide was significantly different between pwRRMS with and without disability. The correction of confounding factors in this study highlights the importance of isolating CEST effects in the cervical spinal cord for more specific characterization and to better understand changes in tissue pathology and relationship to disease severity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.